The same day a report upheld dozens of allegations against MasterChef UK host Gregg Wallace, the BBC found itself in strife ...

Last week we reported on an anti-competition investigation into Spotify launched by Türkiye’s competition regulator Rekabet ...

Astra said its experimental drug Baxdrostat reduced the blood pressure of patients who have a treatment-resistant form of ...

AstraZeneca’s drug candidate baxdrostat lowered systolic blood pressure in a phase 3 clinical trial involving patients with uncontrolled or treatment-resistant hypertension. In the trial, patients who ...

The Financial Stability Board (FSB), has issued its latest report on the ongoing work to address the financial risks posed by ...

Baxdrostat, which AstraZeneca acquired in a 2023 buyout of CinCor Pharma, could become a new treatment for people whose hypertension is either uncontrolled by or resistant to existing medicines.

However, Waters has announced plans to merge with BD's life science and diagnostics segment in early 2026, which will dilute that interest in that highly regulated end market, going forward. The ...

As the financial services sector focuses on sustainability, innovative technologies will be vital to support operations and ...

Federal regulators repeatedly granted appeals to remove Camp Mystic’s buildings from their 100-year flood map, as the camp ...